In vivo success - peptide vaccine in Herpes Simplex Virus
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Successful Delivery of CRIPR/Cas9 into Cells ex vivo
- FNA Presentation
- AGM Company Presentation
- Sept 2018 Quarterly Operations Update and App4C
- Fourfold Delivery Improvement in a New Lead Candidate
Later from PYC Therapeutics
- In Vivo Success - peptide vaccine (Amended Graphics)
- CEO letter and Operational Update
- Dec 2018 Operational Update and App4C
- First Competitive Read Out - Peptide Vaccine
- Flagship Program - Successful Animal Models
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics